Answers are grounded in this paper and cite their sources.
Analysis reveals layilin downregulates CD8+ T cell function in hepatocellular carcinoma, suggesting its utility as a prognostic biomarker.
Layilin (LAYN) represents a valuable prognostic biomarker across various tumor types, while also serving as an innovative indicator of dysfunctional or exhausted CD8
No takes yet. Share an insight, caveat, or question.
Xiao et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: